BNGO BioNano Genomics upside potenial, huge volume coming

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.
Net Income $-29,820,000.00
Market Cap $69.23 million
Annual Sales $10.13 million

BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share.

If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.

If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.